News!

 

        

Commentaries

 

        

Capticasts

 

        

Member Login

Poll

Should chlorthalidone be the preferred thiazide diuretic for the treatment of hypertension?:

Who's online

There are currently 0 users and 6 guests online.

Can a Vitamin a Day Keep Cancer Away?

Commentary Written By: 
Lindsay Jackson, Pharm.D. and Julia Nickerson-Troy, MS, Pharm.D., BCACP

Millions of Americans take a multivitamin daily. Millions do not. Should healthcare providers recommend a daily multivitamin to patients who do not already take one? Or discourage those who do?

Average: 5 (1 vote)

Is Zidovudine Enough?

Commentary Written By: 
Krystal Canally, PharmD and Melody L. Hartzler, PharmD, AE-C

The World Health Organization (WHO) estimates that only 53% of pregnant women worldwide received any antiretrovirals during pregnancy to prevent mother-to-child HIV transmission in 2009.  In the absence of any intervention, the risk of transmission is high (upto 45%).1  Therefore it is crucial that infants born to previously untreated mothers receive postexposure prophylaxis.

Average: 5 (1 vote)

The CONQUER Study - Phentermine plus Topiramate for Weight Loss

The CONQUER study was double-blind, placebo-controlled clinical trial that examined the potential benefits of the combination product Qsymia (phenterimine and topiramate) in patients who were overweight and obese.  Our moderator and panelists explore the findings of this study and how this new information should be applied to practice.


Aspirin to Prevent Recurrent VTE? Too Little, Too Late?

Commentary Written By: 
Christina Coakley, PharmD and Augustus (Rob) Hough, PharmD, BCPS

It’s been six months since your patient started treatment for an unprovoked venous clot.  Everything has gone well and you’ve both been planning for this day when warfarin therapy can be stopped.  Now what?

Average: 4.8 (9 votes)

Tiotropium for Uncontrolled Asthma?

The PrimoTinA - asthma studies are two replicate double-blind clinical trials examining the benefits of adding inhaled  tiotropium to standard asthma therapies in patients who have not achieved optimal control.  Our moderator and panelists explore the findings of this study and how this new information should be applied to practice.


β-blockers and Hypertension: Where are the Data?

Commentary Written By: 
Jenna M. Siskey, PharmD, Adraine L. Lyles, PharmD, BCPS, and Dave L. Dixon, PharmD, BCPS

JNC7, now more than a decade old, recommends β-blockers as second line therapy in patients without compelling indications, after a thiazide diuretic, on equal footing with angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, and calcium channel blockers.1   Should this class still play a role in the treatment of hypertension in patients without compelling indications?

Average: 2.9 (69 votes)

Will Insulin Be the Death of Our Patients?

Commentary Written By: 
Arezo Noormohammadi, Pharm.D. and Gloria R. Grice, Pharm.D., BCPS

Does insulin worsen cardiovascular outcomes and cause cancer? Should insulin be reserved as the last resort?

Average: 4.2 (5 votes)

Another Bust for Omega-3 Fatty Acids – It’s Time to go Fishing Elsewhere

Commentary Written By: 
Tonya Coles, Pharm.D. and Dave L. Dixon, Pharm.D., BCPS, CDE, CLS

The biggest superstar in the dietary supplement industry is fish oil.  It is available over-the-counter and you can even buy orange juice fortified with it. Unfortunately, most of these products contain very low amounts of omega-3 fatty acids (O3FA).

Average: 4.7 (3 votes)